Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Calendar Review
JCCC Research Seminar Featuring Dr. Harvey Herschman
COX-2 and Cancer
Date: 10/24/2013
Time: 12:00 PM - 1:00 PM
Cost: Free
Location: 73-105 CHS
10833 Le Conte Ave.
Los Angeles, California 90095

JCCC SeminarDr. Harvey Herschman

Presented by:
Harvey Herschman, Ph.D.
Distinguished Research Professor
Departments of Pharmacology and Biological Chemistry
Member, JCCC Cancer Molecular Imaging Program Area

Dr. Harvey Herschman's laboratory discovered the COX-2 gene, the target of the anti-inflammatory drugs Celebrex and Vioxx. Elevated COX-2 is a hallmark of many cancers such as colon, lung and breast. He and his colleagues are interested in the role of COX-2 in the initiation and progression of cancers. To study these areas, they are developing mouse models in which COX-2 can be conditionally over-expressed or suppressed in specific target tissues.

Light lunch served

Sponsored by the JCCC Cancer Molecular Imaging Program Area